Atai Life Sciences N.V. (ATAI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Sales | 40 | 273 | 0 | 18 | 87 |
| Gross Profit | 40 | 273 | N/A | 18 | 87 |
| Operating Expenses | 22,642 | 26,002 | 24,085 | 33,579 | 26,921 |
| Operating Income | -22,602 | -25,729 | -24,085 | -33,561 | -26,834 |
| Interest Expense | 783 | 702 | 687 | 690 | 686 |
| Other Income | -3,104 | -30,919 | -2,610 | 15,538 | 71,129 |
| Pre-tax Income | -26,489 | -57,350 | -27,382 | -18,713 | 43,609 |
| Income Tax | -178 | 19 | -4 | 428 | 238 |
| Net Income Continuous | -26,311 | -57,369 | -27,378 | -19,141 | 43,371 |
| Minority Interests | -25 | -57 | -665 | -850 | -873 |
| Net Income | $-26,286 | $-57,312 | $-26,713 | $-18,291 | $44,244 |
| EPS Basic Total Ops | -0.16 | -0.36 | -0.17 | -0.11 | 0.28 |
| EPS Basic Continuous Ops | -0.16 | -0.36 | -0.17 | -0.12 | 0.28 |
| EPS Diluted Total Ops | -0.16 | -0.36 | -0.17 | -0.08 | 0.25 |
| EPS Diluted Continuous Ops | -0.16 | -0.36 | -0.17 | -0.08 | 0.24 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.36 | -0.17 | -0.12 | -0.14 |
| EBITDA(a) | $-22,519 | $-25,647 | $-24,002 | $-33,460 | $-26,760 |